These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32370746)

  • 1. Metabolic abnormalities exacerbate Sjögren's syndrome by and is associated with increased the population of interleukin-17-producing cells in NOD/ShiLtJ mice.
    Hwang SH; Park JS; Yang S; Jung KA; Choi J; Kwok SK; Park SH; Cho ML
    J Transl Med; 2020 May; 18(1):186. PubMed ID: 32370746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
    Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
    Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
    Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
    J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
    Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 and CCR9
    Hwang SH; Woo JS; Moon J; Yang S; Park JS; Lee J; Choi J; Lee KH; Kwok SK; Park SH; Cho ML
    Front Immunol; 2021; 12():721453. PubMed ID: 34539657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achaete-scute complex homologue 2 accelerates the development of Sjögren's syndrome-like disease in the NOD/ShiLtJ mouse.
    Kim SM; Kwon JE; Park JS; Seo HB; Jung KA; Moon YM; Lee J; Kwok SK; Cho ML; Park SH
    Immunol Lett; 2017 Oct; 190():26-33. PubMed ID: 28728856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren's syndrome.
    Wen J; Zhu F; Yu X; Xie H; Li C
    BMC Immunol; 2022 Oct; 23(1):49. PubMed ID: 36244973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models.
    Zhou J; Felix FA; Jiang Y; Li D; Kim MC; Jang D; Cha S; Yu Q
    Mol Immunol; 2024 Oct; 174():47-56. PubMed ID: 39197397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of CD40 DNA vaccine ameliorates the autoimmune pathology of non-obese diabetic mice with Sjögren's syndrome.
    Zhou YB; Yuan X; Wang QK; Zhang H; Wang GS; Li XP; Wang Y; Harris D; Li XM
    Immunol Lett; 2020 Oct; 226():62-70. PubMed ID: 32707129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
    Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
    J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
    Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
    Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
    Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
    Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
    Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
    J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.
    Parashar K; Schulte F; Hardt M; Baker OJ
    FASEB J; 2020 Jun; 34(6):7733-7744. PubMed ID: 32277856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the Submandibular Salivary Gland Epithelial Cell Subpopulations During Progression of Sjögren's Syndrome-Like Disease in the NOD/ShiLtJ Mouse Model.
    Gervais EM; Desantis KA; Pagendarm N; Nelson DA; Enger T; Skarstein K; Liaaen Jensen J; Larsen M
    Anat Rec (Hoboken); 2015 Sep; 298(9):1622-34. PubMed ID: 26179322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome.
    Cong X; Zhang XM; Zhang Y; Wei T; He QH; Zhang LW; Hua H; Lee SW; Park K; Yu GY; Wu LL
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3154-3163. PubMed ID: 29981359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
    Peck AB; Nguyen CQ; Ambrus J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
    Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
    Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
    Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
    J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.